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Interplay of Murine
Gammaherpesvirus 68 with
NF-kappaB Signaling of the Host
Brandon Cieniewicz†, Alexis L. Santana†, Nana Minkah† and Laurie T. Krug*
Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY, USA
Herpesviruses establish a chronic infection in the host characterized by intervals of lytic
replication, quiescent latency, and reactivation from latency. Murine gammaherpesvirus
68 (MHV68) naturally infects small rodents and has genetic and biologic parallels with
the human gammaherpesviruses (gHVs), Kaposi’s sarcoma-associated herpesvirus and
Epstein–Barr virus. The murine gammaherpesvirus model pathogen system provides a
platform to apply cutting-edge approaches to dissect the interplay of gammaherpesvirus
and host determinants that enable colonization of the host, and that shape the latent
or lytic fate of an infected cell. This knowledge is critical for the development of novel
therapeutic interventions against the oncogenic gHVs. The nuclear factor kappa B (NF-
κB) signaling pathway is well-known for its role in the promotion of inflammation and
many aspects of B cell biology. Here, we review key aspects of the virus lifecycle in the
host, with an emphasis on the route that the virus takes to gain access to the B cell
latency reservoir. We highlight how the murine gammaherpesvirus requires components
of the NF-κB signaling pathway to promote replication, latency establishment, and
maintenance of latency. These studies emphasize the complexity of gammaherpesvirus
interactions with NF-κB signaling components that direct innate and adaptive immune
responses of the host. Importantly, multiple facets of NF-κB signaling have been
identified that might be targeted to reduce the burden of gammaherpesvirus-associated
diseases.
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GAMMAHERPESVIRUS INFECTION AND ASSOCIATED
MALIGNANCIES
Features of Gammaherpesviruses
The gammaherpesviruses (gHVs) represent an ancient and highly successful family of viruses that
coevolved with their hosts over the course of 60–80 million years (Davison, 2002). As a subfamily of
the herpesviridae, the gammaherpesvirinae are characterized by an encapsidated double-stranded
DNA genome that encodes 70–80 open reading frames (Parker et al., 1990; Russo et al., 1996;
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Virgin et al., 1997). In addition to protein coding genes, the
gHVs encode non-coding RNAs including miRNAs (Pfeffer
et al., 2004, 2005). Herpesvirus virions are surrounded by
a lipid envelope that contains numerous glycoproteins that
mediate entry into the cell. Another characteristic of the
herpesvirus virion is the tegument, a structured proteinaceous
layer located between the capsid and the lipid envelope.
Tegument proteins are delivered into the cytoplasm of the
infected cell immediately upon infection and many play crucial
roles in early infection.
A hallmark of herpesvirus infection, including that of the
gHVs, is the ability to switch between two distinct phases:
lytic infection and latency. Lytic infection is characterized by
expression of a majority of viral genes in a regulated cascade of
gene expression, replication of viral DNA as linear concatemers,
and production of infectious virions. Latency is defined by
extremely restricted viral gene expression, the maintenance of
the viral genome as a circular non-integrated episome tethered
to the cellular genome (Yates and Guan, 1991; Ballestas et al.,
1999; Lee et al., 1999; Collins et al., 2002; Habison et al., 2012),
and the ability to switch from latent infection to productive virus
infection, a process known as reactivation. GHVs infect a wide
range of cell types, including epithelial cells (Sixbey et al., 1983,
1984), endothelial cells (Boshoff et al., 1995), monocytes (Weck
et al., 1999b), and lymphocytes (Alfieri et al., 1991; Sunil-Chandra
et al., 1992a) (Table 1). The predominant cellular reservoir of
latency is lymphocytes; the human gHVs target the mature B
cell compartment (Ambroziak et al., 1995; Babcock et al., 1998;
Hassman et al., 2011).
The Human Gammaherpesviruses Are
Associated with Cancer
Within the gHVs there are two known human gHVs; EBV
(Epstein–Barr virus, human herpesvirus-4), is the prototypical
member of lymphocryptoviridae, and KSHV (Kaposi’s sarcoma-
associated herpesvirus, human herpesvirus-8), is the prototypical
member of the rhadinoviridae. EBV infects over 95% of
adult humans, while KSHV infection varies by geographical
location and HIV infection status. EBV infection is associated
with the development of Burkitt’s lymphoma, Hodgkin’s
lymphoma, and nasopharyngeal carcinoma (Table 1). KSHV
infection is the etiological agent of Kaposi’s sarcoma and is
associated with primary effusion lymphoma and multicentric
Castleman disease (Verma and Robertson, 2003; Cesarman,
2014). Immunocompromised patients, such as individuals co-
infected with HIV and either gHV, have a greatly increased
incidence of malignancies (Simard and Engels, 2010; Jha
et al., 2016). Despite the effectiveness of HAART therapy in
controlling HIV, both gHV-induced lymphomas remain the most
common cancer-related cause of death in HIV-infected patients
(Simard et al., 2011). EBV infection also causes post-transplant
lymphoproliferative disorder (PTLD). Immunosuppressive drugs
used to prevent transplant rejection impair T cell control of the
latent infection, leading to the emergence of EBV-infected cells
with a less restricted latency program that can drive proliferation
of virally infected cells (Landgren et al., 2009; Rasul et al., 2012;
Tse and Kwong, 2015).
MURINE GAMMAHERPESVIRUS 68
(MHV68) INFECTION OF MICE AS A
MODEL SYSTEM OF
GAMMAHERPESVIRUS PATHOGENESIS
Value of a Small Animal Pathogen
System
Due to the ineffectiveness of current antiviral therapies in
combating latent infections and the lack of vaccines, a detailed
understanding of virus–host interactions is needed for the design
of targeted therapeutics against gHVs. Cell culture-based studies
of the human gHVs have defined the role of many viral and
host factors during infection. The mechanisms by which EBV
and KSHV promote proliferation and survival of the host cell
are likely major risk factors for the development of lymphomas.
However, studies on the role of virus–host interactions and how
they influence pathogenesis in the host have been hampered due
to the inability to perform synchronous de novo infection in cell
culture and the lack of tractable small animal models due to strict
host tropism. Thus, a natural gammaherpesvirus pathogen of
murid rodents provides a relevant and powerful model system
for assaying factors that affect gHV pathogenesis (Simas and
Efstathiou, 1998; Blackman et al., 2000; Speck and Ganem, 2010;
Barton et al., 2011).
Murine Gammaherpesvirus 68 Is
Endemic to Murid Rodents
Murine gammaherpesvirus 68 (MHV68, formally identified as
murid herpesvirus 4) is a natural pathogen of murid rodents used
to study virus–host interactions in the context of a whole animal.
MHV68 was originally isolated from bank voles in the former
Soviet republic of Czechoslovakia (Blaskovic et al., 1980), and
has since been identified in yellow-necked wood mice in England
(Blasdell et al., 2003), indicating that MHV68 may be endemic to
European rodent populations. MHV68 productively infects, and
establishes latency in, all tested strains of Mus musculus.
Genomic Similarities to Primate
Gammaherpesviruses
Murine gammaherpesvirus 68 shares genomic, biologic, and
pathologic properties with primate and human gHVs (Table 1).
MHV68 is classified as a Rhadinovirus along with KSHV and
herpesvirus saimiri (HVS, saimiriine herpesvirus 2). The genome
of MHV68 is ∼128 kb, and encodes for an estimated 80 ORFs
that are largely organized in gene blocks similar to the genomes
of HVS, KSHV, and EBV (Efstathiou et al., 1990a,b; Virgin
et al., 1997; Simas and Efstathiou, 1998). Transposon mutagenesis
screening of MHV68 genes identified a number of genes essential
for virus growth that are conserved within the gHV family
(Moorman et al., 2004; Song et al., 2005).
As found for other gHVs, MHV68 encodes genes that were
likely acquired from the host (Virgin et al., 1997) including a
viral homolog of the cellular anti-apoptotic bcl-2 protein (vBcl-
2, MHV68 M11), a homolog of an IL-8 receptor (vGPCR,
MHV68 ORF74), cyclin D (v-cyclin, MHV68 ORF72), and the
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TABLE 1 | Comparison of select gammaherpesviruses.
Murine gammaherpesvirus
68 (MHV68)
Herpesvirus saimiri
(HVS)
Kaposi’s sarcoma-associated
herpesvirus (KSHV)
Epstein–Barr virus (EBV)
Formal name Murid herpesvirus 4 Saimiriine herpesvirus 2 Human herpesvirus 8 Human herpesvirus 4
Classification Rhadinovirus Rhadinovirus Rhadinovirus Lymphocryptovirus
Natural host Wood mice Squirrel monkey Humans Humans
Transmission Likely sexual Likely by contact, fomites,
aerosol
Saliva, sexual Saliva, sexual
Associated
diseases
Increased incidence
lymphoproliferative disease,
lymphoproliferative disease and
fibrosis in immune deficient
mice
Hematologic malignancies
in non-native new world
primates
Primary effusion lymphomas, Kaposi’s
sarcoma, Multicentric Castleman’s
disease, AIDS-associated
lymphoproliferative disease
Infectious mononucleosis,
Burkitt’s lymphoma, gastric
carcinoma, nasopharyngeal
carcinoma, Hodgkin’s
disease, post-transplant
and AIDS-associated
lymphoproliferative disease
Cell targets Endothelial cells, epithelial cells,
fibroblasts, B lymphocytes,
dendritic cells macrophages
Epithelial cells, T
lymphocytes
Endothelial cells, B lymphocytes,
monocytes, epithelial cells
Epithelial cells, B
lymphocytes
Major latency
reservoir
B lymphocytes, Macrophage
cells
T lymphocytes B lymphocytes B lymphocytes
Latency
maintenance
Episome tethering to host
chromosome via LANA,
chromatin silencing
Episome tethering to host
chromosome via LANA,
chromatin silencing
Episome tethering to host chromosome
via LANA, chromatin silencing
Episome tethering to host
chromosome via EBNA1,
chromatin silencing
Triggers of
reactivation
Terminal differentiation to
plasma cells, inhibition of
histone deacetylases, TLR
stimulation, induced expression
of viral transactivator RTA
Inhibition of histone
deacetylases, induced
expression of viral
transactivator RTA
Inhibition of histone deacetylases,
induced expression of viral
transactivator RTA
Terminal differentiation to
plasma cells, inhibition of
histone deacetylases,
induced expression of viral
transactivators Zebra and
RTA
complement regulatory protein (MHV68 ORF4; Virgin et al.,
1997). MHV68 M11 exhibits both anti-apoptotic and anti-
autophagic functions (Ku et al., 2008; Sinha et al., 2008; Xiaofei
et al., 2009), and functions to promote the survival of infected
immature B cells (Coleman et al., 2014). MHV68 expresses
the vGPCR (ORF74), a chemokine receptor with homology to
human CXCL2, during latency (Virgin et al., 1997; Wakeling
et al., 2001). MHV68 vGPCR is not constitutively active, however,
it is activated by a wide array of cytokines containing ELR motifs
to activate signaling pathways including nuclear factor kappa
B (NF-κB) and Akt (Verzijl et al., 2004), and it can transform
NIH3T3 cells in culture (Wakeling et al., 2001). The MHV68
v-cyclin promotes replication and reactivation in vivo (Upton and
Speck, 2006), contributes to the immortalization of fetal liver B
cells (Liang et al., 2011) and drives lymphomagenesis (van Dyk
et al., 1999).
While many proteins involved in lytic replication are largely
conserved amongst the gHVs, each gHV encodes unique genes.
MHV68 contains both unique genes and non-coding RNAs
(Bowden et al., 1997; Virgin et al., 1999; Reese et al., 2010;
Zhu et al., 2010). The MHV68 genome encodes 14 unique M
genes that are located throughout the viral genome, many have
immunomodulatory functions that promote chronic infection
(Evans et al., 2008; Siegel et al., 2008; Hughes et al., 2011). The left
end of MHV68 encodes eight non-coding RNAs termed TMERS,
viral tRNA-like molecules embedded with single or multiple
3’ miRNAs, that are expressed during latency and productive
infection (Bogerd et al., 2010; Feldman et al., 2014). Recent work
has uncovered a role for the viral TMERs in viral dissemination
and latency establishment in wild-type (WT) mice, as well as
pneumonia in an immunocompromised host (Feldman et al.,
2014, 2016; Diebel et al., 2015). Specific targets for the miRNAs
and the function of the tRNA-like molecules have not been
determined.
Pathogenic Features Common with
Primate and Human
Gammaherpesviruses
Murine gammaherpesvirus 68 also shares pathogenic similarities
with both the primate and human gHVs (Table 1). MHV68
undergoes a subclinical period of acute replication upon infection
of the nasal or respiratory mucosal tissue (Rajcani et al., 1985;
Sunil-Chandra et al., 1992b; Milho et al., 2012). Productive
lytic infection in the lung causes localized tissue damage that
undergoes normal repair (Ehtisham et al., 1993). The initial
infection is cleared from the lungs by 12 days post infection
in BALB/c and C57BL/6 mice (Sunil-Chandra et al., 1992b;
Cardin et al., 1996), then trafficked by B cells to the spleen
(Usherwood et al., 1996c). MHV68 infection is associated with
an expansion of lymphocyte populations that drives an infectious
mononucleosis-like response marked by enlarged lymph nodes
and splenomegaly (Usherwood et al., 1996a; Tripp et al., 1997;
Flano et al., 2002b).
Upon gaining access to the spleen, MHV68 establishes latency
in germinal center B cells (Collins et al., 2009). Levels of latency
in the spleen contract by 3–4 weeks post-infection, and the
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predominant reservoir of viral latency shifts to the memory B
cells as found for EBV (Miyashita et al., 1995, 1997; Babcock
et al., 1998; Flano et al., 2002a; Willer and Speck, 2003). Immune
competent animals typically control latent infection, but long-
term studies reported a higher incidence of lymphomas between
6 months and 3 years post infection compared to uninfected mice
(Sunil-Chandra et al., 1994). The latently infected B lymphoma
cell line, S11, was derived from long-term MHV68-infected
mice that spontaneously developed lymphoproliferative disease
(Usherwood et al., 1996b). Additional immunosuppression
via cyclosporine A administration, the loss of T cells or
interferon gamma signaling increases the prevalence of
lymphoproliferative disease, mirroring the development of
gHV-associated malignancies in immunosuppressed humans
(Sunil-Chandra et al., 1994; Tarakanova et al., 2005, 2008; Lee
et al., 2009). In addition, MHV68 can drive fetal liver B cell
immortalization and latency programs are associated with the
development of B cell lymphomas in mice (Liang et al., 2011).
Genetic Manipulation of Virus and Host
Determinants
The MHV68 pathogenesis system allows for the mutation of
host or viral genes, enabling in vivo analysis of determinants
of viral pathogenesis. The MHV68 genome is cloned as a
bacterial artificial chromosome system (BAC), allowing for
straightforward mutagenesis of the viral genome in E. coli (Adler
et al., 2000; Tischer et al., 2010). To better track the course of
infection in vivo, several reporter viruses have been generated.
These include a constitutively expressed YFP, a lytic promoter-
driven luciferase marker, or direct reporter fusion with the major
latency protein LANA (Hwang et al., 2008; Collins et al., 2009;
Nealy et al., 2010). Likewise, the mouse system offers a wide
array of germline and inducible knockouts of host genes to
identify host determinants of infection and to facilitate a better
understanding of the virus–host interactions that occur during
multiple stages of infection. Coupling a virus with a reporter
gene flanked by loxP sites with transgenic mice that express Cre
in specific cell types has been applied to track the cells that
MHV68 infects en route to the latency reservoir (Gaspar et al.,
2011).
In addition, the accessibility of lytic and latent tissue culture
models and the ability of MHV68 to replicate to high titer
in tissue culture facilitate mechanistic studies in vitro. MHV68
replicates in murine fibroblasts, endothelial, epithelial, dendritic
cells, and macrophages, with a single round of lytic replication
lasting 12–18 h (Speck and Ganem, 2010). B cells can be de
novo infected in vitro, albeit with low efficiency, and latent B cell
lines have been established (Usherwood et al., 1996b; Forrest and
Speck, 2008; Liang et al., 2011). Together, these systems allow for
examination of multiple aspects of the viral life cycle in vitro.
COURSE OF MHV68 INFECTION IN MICE
Routes of Transmission
Epstein–Barr virus and KSHV are primarily contracted through
the oral mucosa, and initial infection is often subclinical. EBV
infection can lead to acute infectious mononucleosis (AIM),
especially when contracted in adolescence or early adulthood
(Hoagland, 1964). AIM patients generally exhibit symptoms
many weeks after infection; thus, the initial kinetics of EBV
replication in the oral epithelium and latency establishment of
B cells are not well-understood (Sixbey et al., 1984; Dunmire
et al., 2015). Natural transmission of MHV68 between animals
is not clearly defined. MHV68 can readily infect the nasal and
respiratory mucosa upon intranasal infection (Tan et al., 2014),
but it is unclear if this occurs in the wild. MHV68 and the closely
related MHV72 may undergo vertical transfer from mother to
pup, as viral DNA can be detected in the breast milk of infected
dams and stomachs of the pups (Raslova et al., 2001; Stiglincova
et al., 2011). However, bone fide vertical transmission was not
observed since latency was not established in the pups (Francois
et al., 2013). Co-housing of latently infected animals with naïve
same-sex animals is insufficient for horizontal transmission
(Francois et al., 2013).
Recent studies support a sexual mode of transmission for
MHV68. Epidemiologic studies of wild mice found the highest
prevalence of infection in the heaviest, most sexually active males
(Telfer et al., 2007). High titers of virus inoculum applied to the
vagina of mice led to intranasal infection of naïve mice (Milho
et al., 2012). Intermittent virus replication has been reported in
the genitalia of intranasally infected mice during latent infection
(Francois et al., 2013). Indeed, MHV68 was transmitted from a
female reactivating at the genitalia to a naïve male upon sexual
contact (Francois et al., 2013).
Virus Colonization of the Host
Infection of mice with MHV68 has given us insight into
how gHVs ultimately gain access to the B cell memory
reservoir. Viruses that mark infected cells have been coupled
with cell-specific knock-out or ablation approaches to reveal
a complex series of events that culminate in colonization
of the spleen (Gaspar et al., 2011; Frederico et al., 2012,
2014a,b, 2015). The virus likely undergoes sequential infection
of multiple cell types during transit from the site of initial
infection- nasal or lung tissue in laboratory settings- to the
draining lymph nodes and the spleen (Figure 1). MHV68
infection in vivo does not result in high levels of cell-free
virus (Sunil-Chandra et al., 1992a), and the virus depends
on cell-to-cell spread for efficient propagation (May et al.,
2005). Hematogenous dissemination is likely involved; deletion
of MHV68 non-coding RNA TMER4 is sufficient to reduce
viral burden in peripheral leukocytes and impair infection of
the spleen and peritoneal cavity (Feldman et al., 2016). In
the absence of B cells, seeding of the secondary lymphoid
tissues is significantly decreased, and mice do not develop
an infectious mononucleosis-like syndrome (Usherwood et al.,
1996c; Chao et al., 2015). Even in the absence of B cells,
latency is detected in the spleen at late times post infection,
suggesting alternative routes that allow access to distal reservoirs
of latency (Weck et al., 1996). MHV68 latency in non-B cells
such as macrophages requires the function of v-cyclin to drive
reactivation and maintain the viral reservoir (van Dyk et al.,
2003).
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FIGURE 1 | Course of an MHV68 infection in mice. Acute lytic replication occurs in the lung (intranasal infection) or in the spleen (intraperitoneal infection).
Ongoing replication is cleared typically by 12 days. The peak of latency is measured around 16 days post-infection in secondary lymphoid tissues such as the
spleen. Maintenance of latency is typically evaluated 42 days post-infection. B cells are the predominant latency reservoir, followed by macrophages, dendritic cells,
and endothelial cells. Lymphomas arise at late stages in immunocompromised animals.
Upper Respiratory Tract Infection
Intranasal infection without the use of anesthetic delivers the
viral inoculum into the upper airways (Tan et al., 2014). Upon
inoculation of the upper respiratory tract infection, MHV68 first
infects the neuroepithelium of the rostral nasal cavity (Frederico
et al., 2012; Milho et al., 2012). Infection of the neuroepithelium
is dependent on viral heparin sulfate-binding glycoproteins
(Milho et al., 2012). From here, infection progresses to the
draining superficial cervical lymph nodes via dendritic cells,
after which the virus transits to the spleen (Milho et al.,
2009; Gaspar et al., 2011). Upper respiratory tract infection
leads to similar levels of splenic latency in the spleen as that
obtained from deeper lung infection; however, there is a kinetic
delay in viral colonization of the spleen (Milho et al., 2009).
Subcapsular sinus macrophages that filter the afferent lymph
nodes become infected by MHV68, yet produce few infectious
progeny virions. Interestingly, their depletion increased splenic B
cell infection, and led the authors to propose that this cell type
may represent a bottleneck to dissemination (Frederico et al.,
2015).
Lower Respiratory Tract Infection
Murine gammaherpesvirus 68 pathogenesis studies typically
report the inoculation of mice by autonomic deep inhalation
occurring after light anesthesia. A large bolus of liquid is
inhaled deep into the lung, infecting both the upper respiratory
tract as well as the lung epithelium, but neither the trachea
nor bronchi (Milho et al., 2009). Intranasal inoculation leads
to viral attachment to type 1 alveolar epithelial cells and
initial infection of alveolar macrophages (Lawler et al., 2015),
which collect particulate from the alveolar lumen (Geiser,
2002). From these macrophages, infection spreads to type 1
alveolar epithelial cells (Sunil-Chandra et al., 1992a; Nash and
Sunil-Chandra, 1994; Milho et al., 2009; Lawler et al., 2015).
Viral titer increases in the lungs, peaking at 7 dpi, before
being cleared by 12 dpi (Ehtisham et al., 1993), with CD8+
T cells playing a central role in this process (Weck et al.,
1996; Doherty et al., 2001). Interestingly, despite the significant
expansion of virus in the lungs and evidence of inflammatory
infiltrate, tissue repair largely restores lung morphology (Sunil-
Chandra et al., 1992a; Ehtisham et al., 1993; Dutia et al.,
1997). There is significant infection of macrophages in the
lungs by this method, and the virus primarily drains to
the mediastinal lymph node via a dendritic cell-independent
route (Gaspar et al., 2011). The virus then transits to the
spleen in a B cell dependent manner (Usherwood et al.,
1996c).
Role of Productive Replication in
Dissemination and Latency
The influence of acute replication defects in the lung on the
establishment of latency after intranasal inoculation is well
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documented. MHV68 mutants lacking genes necessary for
productive replication or DNA replication fail to establish WT
levels of latency in the spleens of infected mice after intranasal
inoculation (Coleman et al., 2003; Flano et al., 2005; Moser et al.,
2006; Tibbetts et al., 2006; Gill et al., 2009, 2010; Milho et al.,
2011; Minkah et al., 2015). Splenic latency could be partially or
fully restored after altering the route of infection or dramatically
increasing virus dose (Coleman et al., 2003; Flano et al., 2005; Gill
et al., 2009, 2010; Milho et al., 2011; Minkah et al., 2015). Together
these observations imply a critical role for lytic replication in
seeding the latent splenic reservoir after intranasal inoculation.
For many mutants, it remains to be determined if phenotypes
represent an inability to replicate in mucosal tissues at sites of
entry or represent an inability to efficiently infect immune cells
critical for the dissemination of MHV68 to the B cells in the
spleen. Alternatively, some degree of ‘lytic’ gene expression might
be required to establish a latent gene expression in a particular
cell-type.
Seeding of the Germinal Center
The route of MHV68 to the germinal center B cell likely involves
multiple cellular transitions (Gaspar et al., 2011; Frederico et al.,
2012, 2014a, 2015). Blood entering the spleen in a central
arteriole first passes through the macrophage-rich marginal
sinuses. These macrophages are the first splenocytes to become
infected by MHV68, providing an entryway into the white pulp
and expanding lymphocyte reservoir (Frederico et al., 2014a).
Infection of these marginal zone macrophages leads to lytic
infection and the production of virions that are better suited
to infect B cells (Frederico et al., 2012). These virions infect
adjacent marginal zone B cells that carry the virus to the emerging
germinal centers (Frederico et al., 2014a). Marginal zone B cells
associate with and deposit virions onto the follicular dendritic
cells (Frederico et al., 2014a). The dendritic cells then seed the
expanding population of germinal center B cells, where latent
infection is detected at the highest frequency (Sunil-Chandra
et al., 1992b). Although the germinal center B cell response
subsides after the 14–18 dpi peak, latency is maintained in
germinal center B cells as well as memory B cells at late times after
infection (Flano et al., 2002a; Willer and Speck, 2003; Nealy et al.,
2010). T follicular helper cells play a critical role by supporting
germinal center formation and infected B cell expansion through
the secretion of the pleiotropic cytokine IL-21 (Collins and Speck,
2014, 2015).
ORF50-null viruses that lack the key lytic gene transactivator,
replication and transcription activator (RTA), are impaired for
splenic latency establishment (Moser et al., 2006; Frederico et al.,
2014a). An ORF50-null mutant failed to seed the marginal zone
B cells as visualized by fluorescence analysis of infected spleen
sections (Frederico et al., 2014a). An ORF27-stop virus, lacking
the gp48 glycoprotein, was only slightly attenuated for lytic
replication in cell culture but was greatly impaired for latency
establishment upon intraperitoneal inoculation (May et al., 2005).
As with the ORF50-mutant, the ORF27 mutant remained in
the marginal zone macrophage cells and did not seed B cells
in the white pulp (Frederico et al., 2014a). Taken together,
defects in lytic replication and intercellular spread impact latency
establishment in the B cell reservoir, even when the virus is
administered by a more direct route. Examination of trafficking
defects in additional mutants are needed to validate and extend
this developing model for MHV68 dissemination.
While these trafficking studies provide insight into the
pathogenesis of gHV infection, it is important to note that there
are differences in the splenic architecture of mice and humans. In
humans, the marginal sinuses and associated macrophages reside
more proximal to the follicle in a region called the perifollicular
zone, rather than in the more distal marginal zone where the
marginal zone B cells reside in the mouse (Steiniger et al., 1997).
While the path to the germinal center may differ slightly between
species, MHV68 studies suggest that access to the memory B
cell involves transition through multiple cell types, providing
additional strategies to interfere with chronic gHV infection.
Maintenance of Latency
Latency is established in dendritic cells, macrophages, epithelial,
and endothelial cells (Weck et al., 1999b; Flano et al., 2000; Suarez
and van Dyk, 2008), and many B cell subsets (Nealy et al., 2010;
Coleman et al., 2014; Feldman et al., 2016). The peak of viral
latency occurs around 16 days post-infection, but viral genomes
are detectable at late times during chronic infection (Figure 1).
Although MHV68 initially gains access to the germinal center
B cell reservoir, it is predominantly found in immunoglobulin
isotype class-switched memory B cells during long-term latency
(Flano et al., 2002a; Marques et al., 2003; Willer and Speck,
2003). Access to, and establishment of, latency in the memory
B cell reservoir provides the gHV with a long-lived cellular
reservoir that can reside in lymphoid tissue or circulate through
the body (Giesecke et al., 2014). However, memory B cells likely
undergo homeostatic proliferation and terminal differentiation
into plasma cells upon receptor engagement, for instance in the
context of co-infections.
During infection, MHV68 also infects pro-B, pre-B, and
immature B cells in the bone marrow and is detected in immature
and transitional B cells during chronic infection (Coleman et al.,
2010). Depletion of developing B cells reduces latency in the
mature B cells (Coleman et al., 2014). Normal B cell maturation is
dependent on limited survival signals and deletion of self-reactive
cells. Interestingly, MHV68 vBcl-2 functions to prevent apoptosis
following activation of the BCR (Coleman et al., 2014), perhaps
allowing MHV68 infected cells to bypass normal B cell selection
checkpoints.
Reactivation from Latency
Latent cells infected with gHVs can be reactivated using chemical
or biological agents in vitro, but the stimuli for reactivation
in the immune competent host is poorly understood (Murata,
2014). MHV68 has been used to further evaluate reactivation
in vivo. A critical event in induction of reactivation of the gHVs
is the terminal differentiation of the B cell into a plasma cell
(Laichalk and Thorley-Lawson, 2005; Bhende et al., 2007; Sun
and Thorley-Lawson, 2007; Wilson et al., 2007; Yu et al., 2007;
Siegel et al., 2010). This phenomenon appears to be driven by the
transcription factors IRF-4 and XBP-1, which are expressed upon
B cell maturation into plasma cells (Crawford and Ando, 1986;
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Laichalk and Thorley-Lawson, 2005; Matthias and Rolink, 2005;
Yu et al., 2007). The human gHVs are dependent on XBP-1 for
reactivation (Laichalk and Thorley-Lawson, 2005; Bhende et al.,
2007; Sun and Thorley-Lawson, 2007; Wilson et al., 2007; Yu
et al., 2007), while MHV68 requires IRF-4 (Matar et al., 2014).
MHV68 M2 is a latency-associated gene (Virgin et al., 1999) that
promotes B cells differentiation into a plasma cell-like phenotype
(Liang et al., 2009). Deletion of the plasma cell lineage causes a
reduction in reactivation as well as a contraction of the latent
reservoir during long-term infection (Siegel et al., 2010). In vivo
injection of TLR agonists into a latently infected animal drives
reactivation, and results in a higher latent viral load (Gargano
et al., 2009). Stimulation of either CD40 or TLR9 can also drive
reactivation in cell culture (Moser et al., 2005; Ptaschinski et al.,
2010).
A latent gHV is likely influenced by the activation status
of the immune compartment and cytokines in the host. Co-
infection of MHV68 infected mice with the pathogenic helminths
H. polygyrus or S. mansoni induces reactivation (Reese et al.,
2014). The mechanism appears to be IL-4 induction by helminth
infection that reduces IFNγ levels, a cytokine that represses
the expression of the lytic transactivator RTA to promote the
maintenance of viral latency (Reese et al., 2014). Recently,
impairment of autophagy in macrophage cells was found to
suppress reactivation by increasing inflammation and T cell
activation to drive IFN-γ production (Park et al., 2016).
B Cell-Mediated Control of Infection
In addition to serving as the primary reservoir of latency, B
cells contribute to immune control of gHV infection. Studies
in B cell-deficient mice reveal high levels of viral latency and
reactivation in the peritoneum (Weck et al., 1999a), but the
lack of B cells also impairs the development of Vβ4 T cells,
which secrete IFNγ and control viral reactivation (Weck et al.,
1996; Flano et al., 1999). Passive transfer of immune sera into
B cell deficient µMT mice reduces the establishment of viral
latency (Gangappa et al., 2002). Infection of mice lacking CD28,
a costimulatory molecule necessary for T cell support of germinal
center B cells, reveals only slightly reduced latency establishment
and normal antibody response (Kim et al., 2002). However, this
antibody response was poorly neutralizing and rapidly decreased
over time. Depletion of T cells from CD28−/− mice led to
recrudescence of the virus that could be inhibited by passive
transfer of immune sera, indicating that humoral immunity
contributes to the control of latent infection (Kim et al., 2002).
In addition, immunization of mice with a reactivation-deficient
virus generates immune sera that can prevent superinfection
by a WT virus (Tibbetts et al., 2003). Interestingly, neutralizing
antibody can prevent infection of cell types that do not express
Fc receptors, but increases infection of cell types expressing Fc
receptors (Rosa et al., 2007). To tease apart the contributions of
B cell and T cell interactions from the generation of anti-viral
antibody, McClellan et al. (2006) infected mice with a germline
rearrangement of an antibody variable region such that all B cells
to produce antibodies specific to hen egg lysozyme. While virus-
specific antibody was not necessary for control of latent infection,
depletion of CD8+ T cells increased latency and reactivation in
the peritoneum and depletion of either CD4+ or CD8+ caused
increased latency and reactivation in the spleen (McClellan et al.,
2006).
T Cell-Mediated Control of Infection
Numerous studies have identified roles for both CD4+ and
CD8+ T cells in clearance of acute lytic infection in the lungs
(Ehtisham et al., 1993; Cardin et al., 1996; Stevenson et al., 1999b;
Molloy et al., 2011). During long-term infection, loss of CD4+
T cells compromises immune control, leading to recrudescence
in the lungs, progressive pathology, and death (Cardin et al.,
1996; Molloy et al., 2011). Cytotoxic CD8+ T cells also play an
important role in control of early gHV infection; however, their
loss leads to a much different phenotype than that of CD4+
T cell-deficient animals. In Balb/c mice, depletion of CD8+ T
cells after lung infection causes persistent lytic infection in the
lung as well as the spleen and is accompanied by significant
clinical pathology and increased necrosis of the lung (Ehtisham
et al., 1993). This phenomenon is strain-dependent, as C57BL/6
mice depleted of CD8+ T cells suffer delayed clearance from
the lung accompanied by increased viral latency in the spleen
(Stevenson et al., 1999b). In both backgrounds, simultaneous
depletion of CD4+ and CD8+ T cells leads to persistent virus
replication and death (Ehtisham et al., 1993; Stevenson et al.,
1999b).
While T cells play an important role in initial clearance of
viral infection, they are also crucial for control of latent infection.
It is telling that much of the burden of human disease caused
by the gHVs occurs during T cell immunosuppression (Malnati
et al., 2003; Thompson and Kurzrock, 2004; Cesarman, 2014).
CD8+ T cells specific to MHV68 are observed in the infected
mice as soon as 1 week after infection and are critical for
immune surveillance and control of gHV latency (Stevenson
and Doherty, 1998; Stevenson et al., 1999a; Gredmark-Russ
et al., 2008). This response consists of multiple immunodominant
and subdominant T cells that shift over time (Stevenson et al.,
1999a; Freeman et al., 2010). During latency, CD8+ T cells serve
to control viral reactivation at two important sites of latency:
the spleen and the peritoneum (Tibbetts et al., 2002). Latency
establishment occurs normally in the absence of CD4+ T cells
(Stevenson et al., 1999b). Unlike CD8+ T cell KO animals, CD4+
T cell KO mice fail to contract the latent reservoir in the spleen
and suffer a progressive increase in reactivation in the lungs,
eventually leading to death (Cardin et al., 1996). This defect can
be rescued with anti-CD40 antibody treatment in a CD8+ T
cell dependent manner, indicating that CD4+ T cells provide
important costimulatory signals to CD8+ T cells (Sarawar et al.,
2001; Dias et al., 2010).
THE NF-κB SIGNALING PATHWAY
Despite the importance of latency in the viral life cycle, the
mechanisms that drive latency establishment in some cells
types but not others, and the cellular signals that maintain
latency or initiate reactivation are poorly understood. Better
understanding of the host signaling pathways that contribute
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to the establishment and maintenance of a latent infection is
critical for the development of therapeutics against infection
and virus-associated malignancies. The NF-κB pathway is a
signaling process that involves upstream phosphorylation events
that culminate in the proteasomal processing of regulatory
proteins that enable translocation of NF-κB transcription
factors into the nucleus. NF-κB signaling plays a critical
role in many cellular processes, including cell survival and
inflammatory signaling, as well as a central role in B cell
maturation.
In resting cells, NF-κB complexes are retained in the
cytoplasm by inhibitors of NF-κB (IκBs). IκBs are phosphorylated
by IκB kinase (IKK) complexes resulting in activation of
canonical or non-canonical NF-κB pathways. The NF-κB family
consists of five subunits, p65 (RelA) RelB, cRel, p50/p105 (NF-
κB1), and p52/p100 (NF-κB2) that can form homo- or hetero-
dimers. Depending on the composition of the dimers and other
variables such as post-translational modification and interactions
with other factors, NF-κB dimers can either induce or repress
gene expression through direct binding to DNA sequences in the
regulatory region of target genes and also through interactions
with other factors (Oeckinghaus and Ghosh, 2009). NF-κB
signaling consists of two distinct pathways; the IKKβ-dependent
canonical pathway (Figure 2), and the IKKα-dependent non-
canonical pathway (Figure 3).
Canonical NF-κB Signaling
The canonical pathway is activated by the IKKα/β/γ complex
and results in IKKβ-mediated phosphorylation and ubiquitin-
mediated proteosomal processing of IκBα proteins, which
sequester NF-κB subunits p50/p65 in the cytoplasm. Degradation
of IκBα unmasks the nuclear localization signals of the subunits,
permitting their nuclear translocation. Canonical subunits have
preferential binding partners, p65 with c-Rel or p50, and p50
dimerizing with itself (Vallabhapurapu and Karin, 2009). These
dimers have subtly different target sequences, and can associate
with other transcription factors to control their target genes
(Urban and Baeuerle, 1991; Kunsch et al., 1992; Perkins et al.,
1992; Bonizzi et al., 2004). The canonical NF-κB signaling
pathway serves a broad range of functions within the body,
contributing to immune activation in response to cytokines and
pro-inflammatory signaling in response to pathogen detection
(Li et al., 2002). These cell surface receptors include: the IL-1R
and the TNFR family of receptors which bind cytokines, TLRs
FIGURE 2 | Canonical NF-κB signaling. Canonical NF-κB signaling is activated by the binding of extracellular ligands. Each receptor family differs in the upstream
signaling molecules used to mediate signaling, but they share activation of TRAF2 and TRAF6. The TRAFs ubiquitinate TAK1, causing TAK1 to be activated and
associate with IKKγ. TAK1 can then phosphorylate IKKβ, which in turn phosphorylates IκBα. Phosphorylated IκBα is degraded by the proteasome, releasing the
canonical transcription factors p65, p50, and cREL. These translocate into the nucleus and activate pro-survival and pro-inflammatory genes.
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FIGURE 3 | Non-canonical NF-κB signaling. Non-canonical NF-κB
signaling is initiated by the binding of cell surface receptors to their ligands.
Trimerization of the receptors recruits TRAF2, cIAP1, and cIAP2 to the
receptor. This changes the specificity of cIAP1/2 ubiquitin ligation from NIK to
TRAF3. TRAF3 is ubiquitinated by this complex and degraded by the
proteasome. The absence of TRAF3 prevents degradation of NIK, leading to
its accumulation. NIK can phosphorylate IKKα. Activated IKKα phosphorylates
p100, inducing its partial degradation by the proteasome. The processed
p100 subunit, p52, associates with RelB and translocates into the nucleus
where it mediates transcription of pro-survival genes.
that recognize pathogen-associated molecular patterns, and the
B and T cell receptors, which provide pro-survival signals. Each
receptor transduces its signal with an overlapping set of effector
molecules that are summarized in Figure 2.
Non-canonical NF-κB Signaling
Non-canonical/alternative NF-κB signaling mediates organo-
genesis, cell maturation, and pro-survival signaling. This pathway
is activated by specific members of the TNFR family, such
as CD40, BAFFR, and TNFRSF3 (LTβR; Matsushima et al.,
2001; Sun, 2012) (Figure 3). In contrast to the canonical
pathway receptors, activated receptors of the non-canonical
NF-κB pathway directly associate with TRAF proteins (Pullen
et al., 1999; Hildebrand et al., 2010) through multiple TRAF
binding sites on their intracellular tails (Pullen et al., 1998). In
resting cells, NF-κB-inducing kinase (NIK), which is the major
IKKα-activating kinase in cells, is constitutively active, but is
present at very low levels due to its constitutive degradation
by cIAP1/2 (Varfolomeev et al., 2007), dependent on TRAF3
and TRAF2 (Liao et al., 2004; Gardam et al., 2008). Relief from
constitutive degradation by receptor engagement and TRAF3
degradation allows for activated NIK to accumulate (Dejardin
et al., 2002; Gardam et al., 2008). This accumulation drives the
phosphorylation of IKKα on two serines in its activation loop
(Regnier et al., 1997; Lin et al., 1998; Ling et al., 1998) and licenses
IKKα to phosphorylate p100 (Senftleben et al., 2001). Full-length
p100 can act similarly to IκBα, sequestering NF-κB subunits in
the cytoplasm. Upon phosphorylation, p100 undergoes partial
proteolysis to p52 that can associate with the NF-κB transcription
factor RelB and translocate to the nucleus to initiate gene
transcription (Xiao et al., 2001; Solan et al., 2002; Bonizzi et al.,
2004). Activated IKKα also serves to negatively regulate the
non-canonical pathway signaling through phosphorylation and
destabilization of NIK (Razani et al., 2010).
Crosstalk between Canonical and
Non-canonical NF-κB Signaling
Extensive research has defined the signaling pathways for
each arm of NF-κB signaling, as well as numerous levels
of crosstalk between these two arms. Full-length p100 may
sequester canonical subunit dimers in addition to RelB in the
cytoplasm, interfering with canonical signaling (Basak et al.,
2007). Canonical NF-κB signaling can influence non-canonical
pathway signaling through the induction of RelB and p100
transcription (Dejardin et al., 2002; Basak et al., 2008). NF-κB1
subunit p50 may compete with p52 for binding to RelB, (Basak
et al., 2008), and p65 can bind p100 and induce its degradation,
leading to the formation of p52/p65 heterodimers (Hoffmann
et al., 2003). The use of common upstream signaling molecules
and the formation of NF-κB heterodimers likely contributes to
extensive overlap in target genes between canonical and non-
canonical NF-κB pathways (Li et al., 2002).
The Role of NF-κB Signaling in B Cell
Development
Nuclear factor-kappa B signaling pathways are utilized by B
lymphoid cells, the primary latency reservoir for gHVs, to
drive transcription of genes important for B cell maturation,
responses to infection, proliferation, protection from apoptosis,
and immunoglobulin isotype class switching (Pasparakis et al.,
2006). B cells develop in the bone marrow where they undergo
VDJ recombination and emerge with a functional heavy and light
immunoglobulin chain (Ichii et al., 2014). The B cells emerge
into the periphery as transitional 1 (T1) B cells, characterized
as CD23lo IgMhi (Hsu et al., 2002), and home to secondary
lymphoid organs (Figure 4). Successful entry to the periarteriolar
lymphoid sheath of the spleen (Loder et al., 1999) exposes the
nascent B cell to peripheral selection by BAFF signaling. BAFF is
secreted by numerous cell types in the spleen, including myeloid,
dendritic, and stromal cells (Nardelli et al., 2001; Litinskiy et al.,
2002; Gorelik et al., 2003). BAFF binds primarily to the BAFF
receptor (BAFFR) on B cells, inducing pro-survival Bcl-2 family
members (Claudio et al., 2002) and down-regulating apoptotic
genes (Craxton et al., 2005) through non-canonical NF-κB, Akt,
and ERK signaling in an IKKα-dependent manner (Claudio et al.,
2002; Patke et al., 2006; Otipoby et al., 2008; Woodland et al.,
2008; De Silva et al., 2016). BAFF, BAFFR, or IKKα- knockout
cells mature and exit the bone marrow but undergo apoptosis
upon entry to the spleen, reducing the transitional 2 (CD23hi
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FIGURE 4 | Role of NF-κB signaling in B cell maturation and
differentiation. B cells exit the bone marrow and home to secondary
lymphoid organs. The B cell exits from the arteriole into the peripheral arteriole
lymphoid sheath (PALS) as a T1 B cell. Here, the B cell requires BAFF
signaling to survive and mature to a T2 B cell. The T2 B cell can mature to a
marginal zone B cell or follicular B cell. The mature follicular B cell can be
activated by the detection of cognate antigen and CD40 costimulation. The
activated B cell enters the germinal center, where it competes for antigen and
costimulatory factors presented on follicular dendritic cells and produced by T
follicular helper cells. Strong antigen binding and receipt of costimulatory
NF-κB-dependent signaling through CD40 and BAFF allows the B cell to
mature into a memory B cell or a plasma cell.
IgMhi) and mature B cells by up to 95% (Lentz et al., 1996; Kaisho
et al., 2001; Senftleben et al., 2001; Hsu et al., 2002). Conversely,
transgenic expression of BAFF in mice drastically expands the
transitional and marginal zone B cell reservoirs (Batten et al.,
2000). Upon maturation past the T1 phase into the T2 phase, the
nascent B cell relocates to the splenic follicle where it undergoes
BCR-dependent selection (Loder et al., 1999) mediated by the
NF-κB signaling pathway (Lucas et al., 2001; Wang et al., 2001;
Shinohara et al., 2005). Successful activation licenses the T2 B cell
to become a marginal zone or naïve mature follicular B cell (Loder
et al., 1999).
The next step of B cell maturation occurs upon detection
of a cognate antigen for the BCR, accompanied by CD40 co-
signaling, leading to the formation of the germinal center (Goetz
and Baldwin, 2008). CD40 signals through both IKKα and IKKβ
(Kosaka et al., 1999). Mice lacking CD40 fail to form germinal
centers (Goetz and Baldwin, 2008). Germinal centers can form
from the small population of mature B cells in BAFF−/− mice
during infection, although these are short-lived (Rahman et al.,
2003; Vora et al., 2003). Both of the downstream IKKs are
necessary for passage of the B cell through the germinal center
of mice (Goetz and Baldwin, 2008). A dominant negative knock-
in of IKKα (IKKαSSAA) abrogates germinal center formation
(Kaisho et al., 2001; Mills et al., 2007), while conditional deletion
of IKKβ drastically impairs global B cell survival (Pasparakis
et al., 2002). It has been recently shown that conditional deletion
of NIK after passage of the T1 checkpoint impairs the ability
of B cells to enter the germinal center, further confirming the
necessity of non-canonical signaling in the germinal center
reaction (Brightbill et al., 2015).
DISRUPTION OF THE NF-κB SIGNALING
PATHWAYS ALTERS MHV68
PATHOGENESIS
During the course of infection, the gHVs traverse numerous
cell types before gaining access to germinal center B cells, and
ultimately memory B cells. However, the signaling events that
determine the lytic or latent course of infection are not well
understood. The NF-κB signaling pathway is activated during
B cell maturation and differentiation. Numerous gHV proteins
can activate or impair signaling through the expression of viral
proteins and miRNAs. While these viral molecules are important
for latency and infected cell survival in culture, the role of NF-
κB signaling in the gHV lifecycle of the host is not well-defined.
The genetic tractability of the MHV68 pathogenesis system has
enabled the in vivo role of many NF-κB signaling components to
be examined (Table 2).
Role of NF-κB Signaling during Acute
Phase of Infection
Infection with a recombinant MHV68 expressing a dominant-
negative IκBα that blocks canonical NF-κB subunit activity did
not impact viral replication in fibroblasts or lung epithelial cells
in culture, and did not alter levels of acute expansion in the
lungs of infected mice (Krug et al., 2009, 2010). Likewise viral
replication proceeds normally in cells lacking the p50 subunit
(Krug et al., 2009). Thus, NF-κB subunits are dispensable for
MHV68 replication (Krug et al., 2007, 2009, 2010). In contrast,
overexpression of the NF-κB subunit p65 was reported to impair
RTA activation and virus replication, and suggested that NF-κB
signaling is deleterious to lytic gene expression (Brown et al.,
2003a). As detailed in the section describing gHV modulation of
NF-κB signaling below, recent studies have determined that the
virus subverts upstream signaling events while impairing subunit
activation to enhance lytic gene expression (Dong and Feng,
2011; Dong et al., 2012; Karijolich et al., 2015).
The NF-κB p50 subunit is activated during both lytic and
latent infection in vitro (Krug et al., 2009). Germline deletion
of the NF-κB1 subunit that is processed to p50 in mice leads
to higher acute lung replication after intranasal infection (Krug
et al., 2009). The p50−/− mice also exhibited reduced B and
T cell responses upon MHV68 infection. The increase in lytic
replication was rescued in bone-marrow chimeric mice generated
from WT and p50−/− donors, indicating the increased viral
replication is not a cell-intrinsic effect, but rather due to
impaired immune control (Krug et al., 2009). Mice lacking
lymphotoxin alpha (LTα), a homolog of TNFα that signals
through the canonical NF-κB pathway (Medvedev et al., 1996),
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TABLE 2 | In vivo studies of the role of NF-κB signaling on MHV68 pathogenesis.
Gene Knockout Immune defects Route/Dose Impact on pathogenesis Changes in host response Reference
LTα Germline No lymph nodes INa/2 ×105,b ↓ Clearance from lung
↑ Latency
↑ Lung inflammation
↓ CD8+ T cell activation
Lee et al., 2000
CD40 Germline No germinal center
formation
IN/1 × 103 ↑ Reactivation
↑ Infection of naïve B cell
Recrudescence in lungs
Willer and Speck, 2005
CD40 Mixed BM
chimera
IN/4 × 102 Equal latency establishment
Loss of latency in CD40−/−
subset
Exclusion of CD40−/− B cells
from germinal center
Kim et al., 2003
BAFFR Germline ↓ Mature B cells
Impaired Abc
production
IN/1 × 104 ↓ Latency at 30 dpid ↓ Germinal centers
↓ MHV68-specific Ab
Frederico et al., 2014b
IPe/1 × 105 ↑ Viral titer at 3 dpi,
↓ Infection from 8–30 dpi
TLR2/9 Germline IN/5 × 104 ↑ Viral load at 3 dpi Sun et al., 2015
TLR3 Germline IN/1 × 103 None Gargano et al., 2008
TLR7 Germline IP/1 × 105 None Haas et al., 2014
TLR9 Germline IP/1 × 105 ↑ Reactivation
MyD88 Germline ↓ B cell activation IN/1 × 103 ↓ Latency in spleen at 16 dpi
No difference in latency at
90 dpi
↓ B cell activation
↓ Germinal centers
↓ Class switching
Delayed ab production
Gargano et al., 2008
IP/1 × 103 ↑ Reactivation in PECs
↓ Reactivation in spleen
Mixed BM f
Chimera
IN/1 × 103 ↓ Latency ↓ MyD88−/− germinal center
entry
IkBaM Viral Transgene IN/1 × 103 ↓ Latency establishment
↓ Infected lung B cells
Krug et al., 2007
IP/1 × 103 ↓ Viral titer
↓ Latency
p50 Germline ↓ B cell proliferation
↓ Ab levels
↓ Germinal centers
IN/1 × 102 ↑ Viral titers in lung
↓ Latency at 16 dpi
↑ Latency over time
Recrudescence in lungs
↓ Antibody production
↓ Vβ4+ T cell
Krug et al., 2009
Mixed BM
chimera
None IN/1 × 102 Normal lung titers
↓ Latency in p50−/− B cells
Recrudescence in lungs
↓ p50−/− germinal center B
cell
a IN, intranasal infection under light anesthesia.
bDose described as PFU per animal.
cAb, antibody.
ddpi, days post infection.
e IP, intraperitoneal infection.
fBM, bone marrow.
lack lymph nodes and germinal centers in the spleen (Lee
et al., 2000). Upon infection of LTα−/− mice, viral titers
in the lung were increased and clearance was delayed, and
mutant mice had a transient increase in virus replication upon
colonization of the spleen as compared to WT mice (Lee et al.,
2000). The whole body knock-outs emphasize the role of the
immune response in control of acute expansion that can impact
dissemination to the spleen and long-term immune control of
gHV infection.
Interestingly, interferon-γ receptor knockout mice typically
succumb to MHV68 infection via viral persistence that drives
fibrosis of organs including the lung (Mora et al., 2005). Lung
fibrosis and mortality in the IFNγR−/− mice was prevented by
overexpression of a dominant-negative IκBα from a recombinant
MHV68 (Krug et al., 2010). The inhibition of NF-κB subunit
function both reduced viral load and the expression of the
inflammatory chemokines MCP-1 and CXCL12 in the infected
tissues (Krug et al., 2010). Further investigation is required
to determine how NF-κB signaling in the infected tissue
contributes to inflammatory cytokines and immune activation
during infection.
Role of NF-κB Signaling in Latency
Reservoirs of the Host
Numerous in vivo investigations have demonstrated that
disruption of NF-κB signaling can impair MHV68 latency
establishment in B cells and alter long-term immune control
of viral latency (Table 2). LTα−/− mice exhibited increased
levels of latency in the spleen that are accompanied by a
reduction in T cell activation (Lee et al., 2000). The deletion of
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CD40, a cell surface molecule that activates canonical and non-
canonical NF-κB signaling pathways upon CD40L engagement
(Kosaka et al., 1999), prevented germinal center formation and
T-dependent class switching (Kawabe et al., 1994). Although
latency was established in class-switched B cells in CD40−/−
mice at levels comparable to WT mice, reactivation was increased
in the spleen and recrudescence was observed in the lungs of
the CD40−/− mice (Batten et al., 2000; Willer and Speck, 2005;
Kalled, 2006; Frederico et al., 2014b). The absence of MyD88, a
molecule that acts downstream of numerous canonical pathway
receptors, led to a defect in germinal center formation and
a reduction of latency establishment early after infection with
MHV68. However, latency ‘recovered’ to WT levels by late times
post-infection (Gargano et al., 2008). Interestingly, infection of
MyD88−/− mice with the IκBαM-transgenic virus led to an
even greater defect in latency establishment, suggesting that
MyD88 has additional NF-κB subunit-independent effects on
the latency reservoir (Gargano et al., 2008). Germline deletion
of a single NF-κB subunit, p50, led to a significant reduction
in latency establishment (Krug et al., 2009). The defects in B
and T responses to MHV68 infection upon p50 deletion likely
underlie the observed recrudescence in the lungs and increased
viral load in the spleen at later times post-infection (Krug et al.,
2009).
Non-canonical NF-κB signaling is highly active at multiple
stages of B cell development, including entry into the germinal
center (Batten et al., 2000; Kaisho et al., 2001; Senftleben et al.,
2001; Claudio et al., 2002; Vora et al., 2003; Kalled, 2006;
Mills et al., 2007). However, the role of the non-canonical
pathway in MHV68 latency establishment is not well understood.
Deletion of BAFFR, which signals through the non-canonical
NF-κB signaling pathway, impaired B cell maturation and
germinal center formation (Batten et al., 2000; Kalled, 2006).
MHV68 infection of BAFFR−/− mice led to reduced latency
establishment and lower titers of virus-specific IgG (Frederico
et al., 2014b).
Germline deletion of NF-κB components are associated
with altered pathogenesis in the context of a spectrum
of immunodeficiencies, demonstrating the importance of
lymphocyte development and function in the establishment,
and long-term control, of viral latency. However, such complex
phenotypes complicate the determination of the cell-intrinsic
roles of NF-κB signaling for MHV68 latency. Alternative
experimental approaches been used to separate global immune
defects from cell intrinsic effects on MHV68 pathogenesis.
A recombinant MHV68 engineered to express a dominant
negative form of the IκBα protein (MHV68-IκBαM) was used to
block canonical NF-κB signaling only in the infected cell. This
blockade led to a significant reduction of latency establishment
in the lung and splenic B cells of infected mice (Krug et al., 2007).
This defect could not be rescued by overexpression of the anti-
apoptotic protein Bcl-2, suggesting that blockade of canonical
NF-κB signaling led to a defect in latency rather than a defect in
cell survival (Krug et al., 2007). The reduction of latency in the
spleen was durable and accompanied by a reduction in virally
infected B cells of the lungs (Krug et al., 2007). Specific inhibition
of genes in the infected cell has also been accomplished using
expression of Cre recombinase from the virus (Siegel et al., 2010)
and transgenic mice, although this has not been used to probe
the role of NF-κB components. The absence of global immune
defects and the relative ease of recombinant virus generation
makes this an attractive option to tease apart cell intrinsic roles
for NF-κB as well as other signaling pathways.
Another method to examine cell-intrinsic roles during
pathogenesis while avoiding global immune disruption is the
generation of mixed bone marrow chimeric mice. WT stromal
cells and a ∼50–80% proportion of WT bone marrow allow
for the establishment of a normal immune system while setting
the stage for a rigorous competition between a WT and mutant
cell-type of interest for supporting viral latency. In a study of
mixed bone marrow chimeras, MHV68 failed to establish latency
efficiently in the NF-κB1 p50−/− B cells as compared their WT
B cell counterparts (Krug et al., 2009). In addition there was
a more rapid decline in genome+ cells that lacked p50. The
p50−/− B cells suffered from an intrinsic defect in germinal
center participation that correlated with the reduction of splenic
latency. In addition to the establishment defect in the absence of
p50, the persistence of pre-formed infectious virus in the lungs of
the mixed bone marrow chimeras long after normal clearance of
acute phase replication supports a role for NF-κB transcription
factors in the maintenance of latency (Krug et al., 2009).
Abrogation of upstream signaling components also impairs
latency. Infection of mixed MyD88−/− and WT bone marrow
chimeras revealed a defect in latency establishment in the
MyD88−/− B cells that was accompanied by a decrease in
activation, germinal center participation, and Ig isotype class
switching as compared to WT B cells (Gargano et al., 2008).
Infection of mixed CD40−/−/WT chimeras revealed a defect in
the long-term maintenance of latency in CD40−/− but not WT
cells (Kim et al., 2003). Although the frequency of cells harboring
the virus was indistinguishable at 16 dpi, CD40−/− B cells were
present at reduced frequencies in the germinal centers and the
number of CD40−/− B cells harboring latent virus decreased at
late times after infection (Kim et al., 2003). The deterioration in
latency observed in the bone marrow chimeras implies that CD40
engagement and recruitment to the germinal center is important
for homeostatic maintenance in the memory B cells population
(Flano et al., 2003; Kim et al., 2003; Willer and Speck, 2005).
Extrinsic stimulation of latent cells with TLR agonists led to
mixed reactivation outcomes. Stimulation of TLRs 3, 4, 5, and 9
induced reactivation from the A20-HE MHV68+ latent cell line
(Gargano et al., 2009). In contrast, TLR7 and TLR9 stimulation of
the latent S11 cells line led to a NF-κB p65-dependent suppression
of reactivation (Haas et al., 2014). Administration of LPS (TLR4),
R848 (TLR7), or CpG (TLR9) to infected mice led to heightened
reactivation of latent splenocytes in the infected animal (Gargano
et al., 2009), and CpG injection led to an increase in the frequency
of splenic latency in pups and adult mice (Ptaschinski et al., 2010).
The deletion of TLR3, TLR7, or TLR9 or the combination of
TLR2 and TLR9 did not alter latency establishment (Gargano
et al., 2008, 2009; Haas et al., 2014; Sun et al., 2015), but the
TLR9−/− mice were observed to have an increase in reactivation
from latency (Haas et al., 2014). Interestingly, ex vivo treatment
of splenocytes with BAFF slightly reduced reactivation of MHV68
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from WT splenocytes (Williams et al., 2015). NF-κB signaling is
likely involved in these phenotypes, but its direct role has not
been validated.
Synopsis and Future Mechanistic
Investigations of NF-κB Signaling as a
Host Determinant of Pathogenesis
Taken together, canonical NF-κB subunit activation is
dispensable for MHV68 replication in fibroblasts and
immortalized lung epithelial cells in culture, yet critical for
control of virus replication in the lung and latency establishment
in the spleen (Krug et al., 2007, 2009, 2010). Inhibition of
NF-κB signaling via loss of membrane receptors or downstream
signaling components impacts latency at different stages of
chronic infection that coincide with B cell activation, germinal
center differentiation, and the formation of long term memory
B cells (Kim et al., 2003; Willer and Speck, 2005; Krug et al.,
2007, 2009; Gargano et al., 2008). Albeit less investigated, non-
canonical signaling also contributes to B cell functions that are
conducive to MHV68 latency (Frederico et al., 2014b). Recent
studies have revealed the complexity of latency establishment;
there are numerous rounds of infection in multiple cell types
and B cell subsets prior to the infection of, and transit through,
the germinal center (Gaspar et al., 2011; Frederico et al., 2014a).
Most of the studies that examine NF-κB signaling components
have not defined the cellular origin of the block in latency
establishment. Finally, engagement of TLR receptors influences
reactivation from latency, albeit with variable outcomes (Gargano
et al., 2009; Haas et al., 2014).
What remains unclear is the mechanism for these defects.
Are these phenotypes due to a defect in B cell biology and/or
a dysregulation of the viral latency program? We propose that
gHVs have usurped the NF-κB signaling that transpires in B
cells to promote the viral latency program. Thus, it becomes
important to determine if specific viral genes are directly under
the control of NF-κB subunits, and if specific NF-κB binding sites
or responsive elements in the regulatory regions of viral genes
mediate this regulation. This knowledge is critical to target those
regions of the viral genome for mutagenesis and characterization
in vivo. By this approach, the field can genetically separate the role
of NF-κB in B cell biology from its function as a regulator of gHV
gene regulation in vivo.
GAMMAHERPESVIRUS MODULATION
OF THE NF-κB SIGNALING PATHWAY
Modulation by EBV and KSHV
The gHVs encode numerous proteins that modulate or
activate NF-κB signaling during both latent and lytic infection
(Grossmann et al., 2006; Soni et al., 2007; Martin et al., 2008;
Raab-Traub, 2012). During latency, EBV encodes two proteins,
latent membrane protein 1 and 2 (LMP1/2), that mimic B cell
signals that are involved in germinal center reactions and the
process of memory B-cell differentiation. The EBV encoded
LMP1 protein is a constitutively active CD40 receptor homolog
and activates both canonical and non-canonical NF-κB pathways
to promote the survival and proliferation of infected B cells
(Uchida et al., 1999; Grimm et al., 2005; Le Clorennec et al.,
2008; Ersing et al., 2013; Zhao et al., 2014). LMP2A has dual
roles in promoting NF-κB signaling via Syk and Lyn kinases
and enhances LMP1 signaling by controlling LMP1-interacting
cellular TRAF2 transcription (Dawson et al., 2001; Guasparri
et al., 2008). When expressed as single transgenes in mice,
these molecules can promote B cell proliferation and antibody
production, independently of germinal center formation (Rastelli
et al., 2008; Minamitani et al., 2015). However, it is not clear what
the impact of LMP1 and LMP2A activity are on B cell selection
in the normal course of an EBV infection since the B cells
of double LMP1/LMP2A transgenic mice were phenotypically
normal (Hadinoto et al., 2008; Vrazo et al., 2012). EBV lytic genes
may also impact NF-κB signaling. The viral dUTPase encoded
by BLLF3 signals through TLR2 in a MyD88-dependant fashion
(Ariza et al., 2009). In addition, the EBV protein BGLF4 encoded
by ORF36 is a viral kinase that has been shown to phosphorylate
cellular UTX to inhibit NF-κB signaling and promote RTA
transactivation of lytic reporters (Chang et al., 2012).
Kaposi’s sarcoma-associated herpesvirus encodes multiple
factors that activate NF-κB signaling, including the viral-FLICE
inhibitor protein (vFLIP), viral G protein-coupled receptor
(vGPCR), K1, K15, and ORF75. Cells latently infected with
KSHV require activation of NF-κB signaling for survival and
lymphomagenesis (Keller et al., 2000; Guasparri et al., 2004).
KSHV vFLIP expression during latency drives both canonical
and non-canonical NF-κB activation in order to promote cell
survival and proliferation, as well as induce alterations in
morphology (Chaudhary et al., 1999; Liu et al., 2002; Field
et al., 2003; Matta and Chaudhary, 2004; Grossmann et al.,
2006; Guasparri et al., 2006). The lytic KSHV vGPCR gene
product is constitutively active and drives NF-κB signaling and
the expression of proinflammatory chemokines and cytokines
(Arvanitakis et al., 1997; Kirshner et al., 1999; Schwarz and
Murphy, 2001). The role of K1 as an NF-κB activator is cell-
specific; its expression promotes NF-κB signaling in B cells, yet
inhibits it in HEK293 cells (Prakash et al., 2002; Konrad et al.,
2009). K15 is a transmembrane protein that is expressed at low
levels during latency and activates multiple pathways including
NF-κB signaling (Brinkmann et al., 2003; Wang et al., 2007).
Replacement of EBV LMP2A, which acts as a constitutively
active BCR, with K1 and K15 rescues the ability of EBV to
establish immortalized LCL lines (Steinbruck et al., 2015). KSHV
miR-K1 targets the inhibitor IκBα to maintain NF-κB subunit
activation and promote a latent state in PEL cells (Lei et al.,
2010). The KSHV ORF75 tegument protein was identified in an
in vitro screen for NF-κB activators (Konrad et al., 2009). MHV68
ORF75C and KSHV ORF75 are tegument proteins that have been
recently found to activate RIG-I to promote NF-κB signaling (He
et al., 2015), and are discussed further below.
NF-κB Signaling Is Usurped by MHV68
During the herpesvirus lytic life cycle, viral gene expression
follows an ordered cascade beginning with immediate early (IE),
to early (E) and then late (L) genes. The IE protein, RTA is
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FIGURE 5 | Model for the role of canonical NF-κB signaling in
productive infection. Model summarizing recent reports of virus interplay
with canonical NF-κB signaling to promote productive infection. Viral
tegument protein (vFGAMS/vGAT) encoded by ORF75C and host SINE RNAs
induced by infection leads to IKKβ activation and phosphorylation of RTA
(Dong and Feng, 2011; He et al., 2015; Karijolich et al., 2015).
Phosphorylation of RTA increases transactivation of viral genes (Dong and
Feng, 2011). RTA targets NF-κB subunit p65 for degradation to dampen
pro-inflammatory gene expression (Dong and Feng, 2011; Dong et al., 2012).
encoded by open reading frame 50 (ORF50) and is a conserved
gHV transcription factor (Sun et al., 1998; Lukac et al., 1999;
Feederle et al., 2000; Wu et al., 2000; Goodwin et al., 2001).
RTA initiates lytic replication or the switch from latency to lytic
replication by regulating transcription of E and L lytic genes.
For the Rhadinoviridae γ2-herpesviruses, KSHV, RRV, HVS, and
MHV68, RTA has been shown to be necessary and sufficient to
initiate viral lytic replication during de novo infection (Sun et al.,
1998; Feederle et al., 2000; Pavlova et al., 2003; Xu et al., 2005).
Moreover, ectopic expression of RTA in quiescently infected
cells disrupts latency and induces lytic reactivation (Lukac et al.,
1998; Sun et al., 1998; Gradoville et al., 2000; Wu et al., 2000;
Goodwin et al., 2001). The Lymphocryptovirus γ1-herpesvirus,
EBV, requires the viral transactivator protein ZTA (BZLF1) for
lytic replication, and RTA (BRLF1) serves as a critical co-factor
(Ragoczy and Miller, 2001).
A number of cellular proteins such as IRF4 and HMGB-1 have
been identified as co-factors that synergize with MHV68 RTA to
regulate RTA-responsive promoters (Song et al., 2004; O’Flaherty
et al., 2014). However, some cellular factors have been reported
to inhibit gHV lytic replication by inhibiting RTA expression or
activity, thereby promoting latency. For instance, cellular factors
such as PARP-1, KSHV RTA-binding protein (K-RBP), and NF-
κB can antagonize RTA to inhibit lytic replication (Brown et al.,
2003b; Gwack et al., 2003; Yang and Wood, 2007). High levels
of NF-κB p65 have a deleterious effect on gHV lytic replication,
blocking lytic gene transcription and viral replication (Gutsch
et al., 1994; Brown et al., 2003a).
Interestingly, the gHV lytic transactivator proteins inhibit
NF-κB signaling during viral replication. For EBV, the major
lytic transactivator Zta (BZLF1) inhibits transactivation functions
of NF-κB p65 (Morrison and Kenney, 2004). MHV68 and
KSHV RTA proteins have been demonstrated to target p65 for
degradation (Brown et al., 2003b; Yang et al., 2008; Dong et al.,
2012). MHV68 RTA activated in response to MAVS/IKKB leads
to ubiquitin-mediated degradation of p65 that is phosphorylated
on Ser468 (Dong and Feng, 2011; Dong et al., 2012). MHV68
LANA induces the ubiquitination and degradation of p65,
preventing NF-κB-dependent gene expression in 293 cells
(Rodrigues et al., 2009). It is not clear if the major consequence
of RTA degradation of p65 is to impair NF-κB to promote lytic
gene expression or limit the transcription of NF-κB dependent
proinflammatory cytokines (Dong et al., 2010, 2012; Dong and
Feng, 2011) (Figure 5). Although NF-κB signaling is initially
targeted for degradation by viral molecules, NF-κB subunit
activation has been observed at late timepoints, from 12 to
24 hpi, during productive replication in fibroblasts (Krug et al.,
2007, 2010); the impact of this late stage activation is not
known.
Herpesvirus virions contain a tegument layer between the
viral nucleocapsid and the viral envelope. All gHVs encode one
to three tegument proteins with an approximate 140 amino
acid stretch of homology to a cellular enzyme critical for de
novo purine biosynthesis. This enzyme encoded by the Pfas
gene, the formyl-glycineamide-phosphoribosyl-amidotransferase
(FGARATs/FGAMs) catalyzes the fourth step in the de novo
purine biosynthetic pathway (Zhao et al., 2013). The viral
homologs herein termed vFGAMs (also referred to as vFGARATs
or vGAT) have not preserved the known active sites of the
host enzyme and, as such, are not predicted to retain enzymatic
FGARAT activity (Gaspar et al., 2008). So far three functions
have been described for vFGAMs: ND10 antagonism, facilitation
of capsid trafficking in the cytoplasm, and NF-κB activation
(Tsai et al., 2015). In a recent study by He et al. (2015),
MHV68 vFGAM/vGAT (ORF75C) and KSHV ORF75 were
found to recruit host FGARAT/PFAS to deamidate RIG-I.
In turn, activated RIG-I complexed with MAVS and resulted
in the activation of the upstream NF-κB signaling kinase,
IKKβ.
Kaposi’s sarcoma-associated herpesvirus and MHV68 RTA
migrate at higher molecular weight than predicted based on
their amino acid content, from 64 to 90 kDa for MHV68
and 76 to 110 kDa for KSHV (Lukac et al., 1999; Wu
et al., 2001). Phosphatase treatment decreases KSHV RTA
mobility to∼90 kDa suggesting that phosphorylation contributes
in large to the change in RTA protein mobility (Lukac
et al., 1999). Mass spectrometry analysis of KSHV RTA
identified serine/threonine residues that were phosphorylated.
Replacement of residues 634 and 636 from serine to alanine
impairs KSHV RTA transactivation and reduces reactivation
(Tsai et al., 2012). MHV68 RTA is phosphorylated in vitro
by the IKKβ kinase at groups of serine/threonine residues
S550T552S556 (STS) or T561T562S564 (TTS). Alanine replacement
of the residues impairs RTA transactivation and growth of
a TTS mutant virus (Dong et al., 2010). Taken together,
RTA phosphorylation plays a role in regulating RTA-mediated
viral gene expression which impacts gHV lytic replication and
reactivation.
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Murine gammaherpesvirus 68 RTA phosphorylation by IKKβ
enhances RTA transactivation function and promotes RTA
ubiquitin-mediated deagration of p65 (Dong et al., 2010, 2012;
Dong and Feng, 2011) (Figure 5). Since IKKβ also phosphorylates
the NF-κB subunit p65, RTA driven p65 degradation would
presumably serve to limit NF-κB-dependent inflammatory
cytokine production (Dong et al., 2010; Dong and Feng, 2011;
He et al., 2015). An increase in pro-inflammatory cytokine
production and lung inflammatory infiltrate was reported for
MAVS−/− mice during acute MHV68 infection (Dong and
Feng, 2011; Dong et al., 2012). Interestingly, the kinetics of
virus replication were also dramatically altered in the lungs
in the absence of MAVS. Given that overexpression of p65
impairs MHV68 RTA transactivation (Brown et al., 2003b),
the degradation of p65 might further enhance viral lytic gene
expression as well.
Karijolich et al. (2015) recently identified another pathway
that leads to IKKβ activation upon MHV68 infection. In this
study, host short interspersed nuclear elements (SINE) RNAs
were induced upon MHV68 infection. SINE RNAs drove IKKβ
activation and subsequent phosphorylation of RTA to enhance its
transactivation function. MAVS deficiency reduced the activation
of IKKβ but did not abrogate it, suggesting that SINEs may
activate NF-κB by both MAVS-dependent and independent
means (Karijolich et al., 2015). Taken together, upon de novo
infection of permissive cell lines, MHV68 activates upstream NF-
κB signaling events to drive RTA phosphorylation to enhance
lytic gene expression, but impairs downstream NF-κB subunit
activation, likely to prevent inflammatory cytokine production
(Figure 5).
Evasion of Inflammasome
The inflammasome is an intracellular surveillance system that
can respond to both damage-associated and pathogen-associated
molecular patterns (DAMPs and PAMPs). By initiating these
critical inflammatory responses, the inflammasome plays an
important role in innate immune control of numerous pathogens,
including double stranded DNA viruses (Rathinam et al., 2010;
Sun et al., 2015). The inflammasome is both activated and
subverted during human gHV infection in culture (Gregory et al.,
2011; Kerur et al., 2011; Haneklaus et al., 2012; Ansari et al.,
2013; Singh et al., 2013). Caspase-1 is the inflammasome effector
protease that cleaves the proinflammatory cytokines IL-1β and
IL-18. Surprisingly, mice deficient in caspase-1 were not impaired
for the control of acute replication of MHV68 in the lung or
latency in the spleen (Cieniewicz et al., 2015). In contrast to other
herpesviruses, infection with 10 infectious MHV68 particles per
cell does not activate caspase-1 (Cieniewicz et al., 2015; Sun
et al., 2015). The delivery of the ORF64 deubiquitinase as a
tegument protein seemingly drives efficient shuttling of intact
capsids to the nucleus, shielding the foreign viral genomic DNA
from innate sensors that might trigger inflammasome activation
upon infection (Sun et al., 2015). In addition, MHV68 infection
caused a specific reduction in IL-1β production after extrinsic
LPS stimulation or upon co-infection with Salmonella enterica
Serovar Typhimurium (Cieniewicz et al., 2015). Interestingly, this
impairment occurred at the proIL-1β transcript level without
effecting il18 and tnfa mRNA. IL-1β is regulated by NF-κB
signaling, thus RTA was suspected to reduce IL-1β transcription
via its function to degrade p65. However, the downregulation
was independent of the lytic viral transcriptional activator RTA
(Cieniewicz et al., 2015). Taken together, MHV68 impairs the
inflammasome response by both inhibiting sensing and reducing
IL-1β production during the initial stages of infection, likely via
different mechanisms involving virion components and RTA-
independent IE gene products.
IMPACT OF THESE STUDIES
Over the long course of coevolution with their hosts, the gHVs
have evolved strategies to subvert host signaling and immunity,
culminating in the establishment of a life-long infection that
causes little deleterious effect to the host. However, in the
context of immunosuppression, these latent infections predispose
their host to the development of malignancies. Murine gHV
infection of mice serves as a powerful system to investigate the
complex interactions of virus and host factors that contribute to
pathogenesis in a natural host. Impairment of NF-κB signaling
through the use of knockout mice and recombinant viruses has
revealed a critical role for this host pathway in the establishment
of latency in the host B cell latency reservoir (Table 2). Targeted
ablation strategies and experimental determination of the NF-
κB-dependent gene expression profile of the virus and host
are critical to identify roles intrinsic to the infected cell. With
regard to productive replication, de novo infection with MHV68
leads to activation of upstream NF-κB signaling molecules to
enhance transactivation of lytic gene expression and promote
productive replication (Figure 5). A better understanding of the
mechanism of action for the host factors of the infected cell
and the molecular interface between the virus and host will
identify novel therapeutic approaches to disrupt replication and
latency, and ultimately enable the prevention or elimination of
virus-driven malignancies.
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